Scottie Scheffler won his third major title at the 2025 PGA Championship. See how Scottie dressed for success in Nike golf ...

Scottie Scheffler took out his 3-iron for a TaylorMade Qi35 7-wood at the PGA Championship. Here's how you can get one and ...

Tezepelumab demonstrated clinically relevant benefits in specific inflammatory subtypes of COPD - an historically underserved ...

A complete list of the golf equipment Scottie Scheffler used to win the PGA Tour's 2025 CJ Cup Byron Nelson. DRIVER: TaylorMade Qi10 (8 degrees), with Fujikura Ventus Black 7X shaft FAIRWAY WOOD ...

Get ready to tee it up for the season and make sure you have everything you need for the course, we’re talking everything from the best golf bags to even the best golf shoes. Golf season is upon ...

Rounding up the top five are Asia Pacific Breweries Singapore (Heineken Asia Pacific), BMW Group Asia, The Lego Group and GSK. Singapore’s Best Employers 2025 ranks the top 250 firms among ...

GSK’s boss has joined other industry chiefs warning the UK and Europe need to ‘do more’ to support the industry or risk losing jobs and investment cash to the US. The pharma giant’s chief ...

Ladies and gentlemen, a very warm welcome to this GSK Q1 2025 Results Call. My name is Constantin Fest, new head of IR at GSK, and I'm delighted to be joined today by Emma Walmsley, Luke Miels and ...

And even though the price has recovered from that dip, it’s still down 11% year to date. GSK reported a 2% revenue rise at actual exchange rates (4% at constant rates), driven largely by a 17% ...

GSK (NYSE:GSK) reported Q1 2025 results on Wednesday, narrowly beating analysts’ estimates as the British drugmaker’s Specialty Medicines business offset weakness in its Vaccine and General ...

GSK (GSK) came out with quarterly earnings of $1.13 per share, beating the Zacks Consensus Estimate of $1.08 per share. This compares to earnings of $1.09 per share a year ago. These figures are ...

As GSK weathers the storm of sinking vaccine sales and gears up for key launches in its specialty medicines sector, the British drug giant feels prepared for any challenges that U.S. drug import ...